STAGE IIA BREAST CANCER
Clinical trials for STAGE IIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot radiation during surgery aims to zap breast cancer better
Disease control OngoingThis study is testing a new way to give radiation to women with early-stage breast cancer. During their standard lumpectomy and reconstruction surgery, doctors give a single, targeted dose of radiation directly to the area where the tumor was. The goal is to see if this approach …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for tough breast cancer: trial tests Post-Surgery drug options
Disease control OngoingThis study is for patients with a specific, aggressive type of breast cancer (triple-negative, basal-like) where cancer cells remain after initial chemotherapy and surgery. It aims to find out which of two follow-up chemotherapy drugs—platinum-based drugs (cisplatin/carboplatin) …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
One-Shot radiation during surgery could replace weeks of treatment
Disease control OngoingThis study is collecting information on a one-time radiation treatment given right during breast cancer surgery. It aims to see if this single dose, delivered to the area where the tumor was removed, works as well as the standard several-weeks course of radiation for early-stage …
Matched conditions: STAGE IIA BREAST CANCER
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Testing a Two-Pronged attack on breast cancer before surgery
Disease control OngoingThis study tested a treatment plan for people with early-stage breast cancer who had not yet had surgery. The goal was to see if giving strong chemotherapy before surgery, with or without the drug trastuzumab (Herceptin), could shrink tumors effectively and be well-tolerated. Res…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Shorter radiation course tested for breast cancer patients
Disease control OngoingThis large study is comparing two different schedules of radiation therapy given after mastectomy to prevent breast cancer from coming back. It is testing if a shorter 3-4 week schedule is as safe for breast reconstruction and works as well as the standard 5-6 week schedule. The …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC